Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults;Rendez-vous médicaux de groupe dirigés par des pharmaciens pour la gestion du diabète type 2 associé à la dépression

Annals of Pharmacotherapy

Volumn 45, Issue 11, 2011, Pages 1346-1355

  Taveira, Tracey H ^a,b   Dooley, Andrea G ^a   Cohen, Lisa B ^a   Khatana, Sameed Ahmed M ^a   Wu, Wen Chih ^a,b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Depression; Diabetes; Pharmacy practice

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BEHAVIOR THERAPY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES CONTROL; DIABETES EDUCATION; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; EMERGENCY WARD; FEMALE; HEALTH CARE MANAGEMENT; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VETERAN AFFAIR MULTIDISCIPLINARY EDUCATION IN DIABETES AND INTERVENTION FOR CARDIAC RISK REDUCTION IN DEPRESSION;

APPOINTMENTS AND SCHEDULES; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMORBIDITY; DEPRESSION; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EMERGENCIES; FEMALE; HOSPITAL SHARED SERVICES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT CARE; PHARMACISTS; PRACTICE MANAGEMENT, MEDICAL; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 80155161443     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q212     Document Type: Article

References (42)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
2. Fenton JJ, Von Korff M, Lin EHB, Ciechanowski P, Young BA. Quality of preventive care for diabetes: effects of visit frequency and competing demands. Ann Fam Med 2006;4:32-9.
3. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med 2005;165:2631-8.
4. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28:2668-72.
5. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-85.
6. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditure in individuals with diabetes. Diabetes Care 2002;25:464-70.
7. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 1988;11:605-12.
8. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiology 1996;78:613-7.
9. Katon W, Von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004;27:914-20.
10. Ciechanowski P, Katon W, Russo J, Hirsh I. The relationship of depres- sive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003;25:246-52.
11. Lin EHB, Katon W, Rutter C, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med 2006;4:46-53.
12. Simon GE, Katon WJ, Lin EHB, et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 2005;27:344-51.
13. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160: 2101-7.
14. Reiber GE, Boyko EJ, Maynard C, Koepsell TD, Pogach LM. Diabetes in the Department of Veterans Affairs. Diabetes Care 2004;27:B1-2.
15. Egede LE, Osborn CY. Role of motivation in the relationship between depression, self care, and glycemic control in adults with type 2 diabetes. Diabetes Educ 2010;36:276-83.
16. Weinger K. Group medical appointments in diabetes care: is there a future? Diabetes Spectr 2003;16:104-7.
17. Jack L Jr. Diabetes self-management education research: an international review of intervention methods, theories, community partnerships and outcomes. Dis Manag Health Outcomes 2003;11:415-28.
18. Kirsh S, Watts S, Pascuzz K, et al. Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk. Qual Saf Health Care 2007;16:349-53.
19. Edelman D, Fredrickson SK, Melnyk SD, et al. Medical clinics versus usual care for patients with both diabetes and hypertension. Ann Intern Med 2010;152:689-96.
20. Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 2001;24:695-700.
21. Wagner E, Austin B, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001;20:64-78.
22. American College of Physicians-American Society of Internal Medicine. Pharmacists scope of practice. Ann Intern Med 2002;136:79-85.
23. Martin OJ, Wu W-C, Taveira TH, Eaton CB, Sharma SC. Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes: a pilot study. Diabetes Educ 2007;33:118-27.
24. Taveira TH, Friedmann PD, Cohen LB, et al. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ 2010;36:109-17.
25. Georgiades A, Zucker N, Friedman KE, et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007;69:235-41.
26. Williams GC, Freedman ZR, Deci EL. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care 1998;21:1644-51.
27. U.S. Department of Veterans Affairs pharmacy benefits management strategic healthcare group treatment guidelines. http://www.pbm.va.gov/ (accessed 2011 May 1).
28. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, New Jersey: Prentice Hall, 1986.
29. American Diabetes Association. Standards of medical care in diabetes 2006. Diabetes Care 2006;29:S4-42.
30. Rollnick S, Mason P, Butler C. Health behavior change: a guide for practitioners. New York: Churchill Livingstone, 1999.
31. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390-5.
32. UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
33. UKPDS Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). Br Med J 1998;317:713-20.
34. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 2001;101:671-9.
35. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
36. Lowe B, Unutzer J, Callahan C, Perkins A, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004;42:1194-201.
37. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
38. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self care activities measure: results from 7 studies and a revised scale. Dia- betes Care 2000;23:943-50.
39. Katon WJ, Von Korff M, Lin EHB, et al. The Pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004;61:1042-9.
40. Williams JW Jr, Katon W, Lin EHB, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1015-24.
41. Trento M, Passera P, Borgo E, et al. A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. Diabetes Care 2004;27:670-5.
42. United States Office of Personnel Management Federal jobs and employment information. 2010. www.usajobs.com (accessed 2010 Apr 20).